CAR T-Cell Agents Offer Efficacy in Lymphoma, But Additional Approaches Are Needed to Overcome Resistance
Patients with lymphoma have gained several treatment options with the wave of CAR T-cell therapy approvals by the FDA in recent years. However, additional work is required to find better methods to overcome mechanisms of resistance to these agents, …